Modine plans to add manufacturing capacity in India

[ad_1] Grandbrothers Johnson & Johnson (NYSE:JNJ) has received Priority Review designation from the FDA for the Biologics License Application for its drug nipocalimab in the treatment of antibody-positive patients with generalized myasthenia gravis. Nipocalimab was also recently granted Breakthrough Therapy Designation by [ad_2]

[ad_1] uschools/E+ via Getty Images Stock index futures fell on Monday, with Dow futures bottoming the pack, as investors gear up for the last few trading sessions of the year. S&P 500 futures (SPX) -0.1%, Nasdaq 100 futures (US100:IND) -0.1% and Dow futures (INDU) -0.3%. The 10-year Treasury [ad_2]